BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1502016)

  • 1. Delta 2-valproate biotransformation using human liver microsomal fractions.
    Fabre G; Briot C; Marti E; Montseny JP; Bourrié M; Massé D; Berger Y; Cano JP
    Pharm Weekbl Sci; 1992 Jun; 14(3A):146-51. PubMed ID: 1502016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K; Baillie TA
    Drug Metab Dispos; 1993; 21(2):242-8. PubMed ID: 8097692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction.
    Rowland A; Elliot DJ; Williams JA; Mackenzie PI; Dickinson RG; Miners JO
    Drug Metab Dispos; 2006 Jun; 34(6):1055-62. PubMed ID: 16565174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.
    Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
    Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
    J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro glucuronidation of 3'-azido-3'-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form.
    Rajaonarison JF; Lacarelle B; De Sousa G; Catalin J; Rahmani R
    Drug Metab Dispos; 1991; 19(4):809-15. PubMed ID: 1680659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
    Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential action of thyroid hormones and chemically related compounds on the activity of UDP-glucuronosyltransferases and cytochrome P-450 isozymes in rat liver.
    Goudonnet H; Magdalou J; Mounie J; Naoumi A; Viriot ML; Escousse A; Siest G; Truchot R
    Biochim Biophys Acta; 1990 Jul; 1035(1):12-9. PubMed ID: 2116906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10.
    Argikar UA; Remmel RP
    Drug Metab Dispos; 2009 Jan; 37(1):229-36. PubMed ID: 18838507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
    Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
    Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes.
    Miners JO; Lillywhite KJ; Yoovathaworn K; Pongmarutai M; Birkett DJ
    Biochem Pharmacol; 1990 Aug; 40(3):595-600. PubMed ID: 2116803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms.
    Nakajima M; Tanaka E; Kobayashi T; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Jun; 30(6):636-42. PubMed ID: 12019188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7.
    Patel M; Tang BK; Kalow W
    Pharmacogenetics; 1995 Feb; 5(1):43-9. PubMed ID: 7773302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of unsaturated derivatives of valproic acid in rat liver microsomes and destruction of cytochrome P-450.
    Prickett KS; Baillie TA
    Drug Metab Dispos; 1986; 14(2):221-9. PubMed ID: 2870898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.
    King C; Tang W; Ngui J; Tephly T; Braun M
    Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation.
    Lear L; Nation RL; Stupans I
    Biochem Pharmacol; 1992 Aug; 44(4):747-53. PubMed ID: 1510722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain differences in purified rat hepatic 3 alpha-hydroxysteroid UDP-glucuronosyltransferase.
    Green MD; Falany CN; Kirkpatrick RB; Tephly TR
    Biochem J; 1985 Sep; 230(2):403-9. PubMed ID: 3931633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inducibility and ontogeny of rat liver UDP-glucuronyltransferase toward furosemide.
    Rachmel A; Hazelton GA
    Biochem Pharmacol; 1986 Nov; 35(21):3777-82. PubMed ID: 3096336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.